Larvol Delta - CalciMedica-Announces-FDA-Clearance-of-IND-Application-for-Phase-2-Trial-of-Auxora-for-the-Treatment-of-Severe-Acute-Kidney-Injury

Auxora (zegocractin) - CalciMedica

https://www.prnewswire.com/news-releases/calcimedica-announces-fda-clearance-of-ind-application-for-phase-2-trial-of-auxora-for-the-treatment-of-severe-acute-kidney-injury-302060180.html

Feb 13, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next